https://www.marketscreener.com/quote/stock/LANTERN-PHARMA-INC-108225202/news/Lantern-Pharma-Advances-Unique-ADC-Antibody-Drug-Conjugate-Program-Across-Multiple-Solid-Tumor-Can-45962013/?utm_source=telegram&utm_medium=social&utm_campaign=share